Inventor
RAFFERTY MICHAEL FRANCIS
US21 patents
⚠️ This page may combine multiple inventors who share the name “RAFFERTY MICHAEL FRANCIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARNER LAMBERT CO
18 patentsUS6127418AOct 3, 2000
GABA analogs to prevent and treat gastrointestinal damage
WARNER LAMBERT CO81 citations93
US6362174B1Mar 26, 2002
Reduced dipeptide analogues as calcium channel antagonitsts
WARNER LAMBERT CO23 citations92
US6426368B2Jul 30, 2002
Method for preventing and treating alcoholism
WARNER LAMBERT CO20 citations90
US6423689B1Jul 23, 2002
Peptidyl calcium channel blockers
WARNER LAMBERT CO48 citations90
US6117841ASep 12, 2000
Substituted peptidylamine calcium channel blockers
WARNER LAMBERT CO20 citations90
US6251918B1Jun 26, 2001
Aniline derivatives as calcium channel blockers
WARNER LAMBERT CO6 citations73
US6340758B1Jan 22, 2002
Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents
WARNER LAMBERT CO8 citations72
US5654303AAug 5, 1997
Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
WARNER LAMBERT CO8 citations72
US6495715B2Dec 17, 2002
Calcium channel blockers
WARNER LAMBERT CO2 citations62
US6323243B1Nov 27, 2001
Tyrosine-derived compounds as calcium channel antagonists
WARNER LAMBERT CO6 citations62
US6166052ADec 26, 2000
Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
WARNER LAMBERT CO2 citations61
US5874426AFeb 23, 1999
Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
WARNER LAMBERT CO4 citations61
US6316440B1Nov 13, 2001
Reduced dipeptide analogues as calcium channel antagonists
WARNER LAMBERT CO0 citations52
US6180677B1Jan 30, 2001
Tyrosine-derived compounds as calcium channel antagonists
WARNER LAMBERT CO0 citations52
US6469038B1Oct 22, 2002
Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
WARNER LAMBERT CO0 citations51
US6110911AAug 29, 2000
Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
WARNER LAMBERT CO1 citations51
US6455698B1Sep 24, 2002
Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents
WARNER LAMBERT CO0 citations50
US6251919B1Jun 26, 2001
Heterocyclic substituted aniline calcium channel blockers
WARNER LAMBERT CO0 citations41